175 related articles for article (PubMed ID: 32867140)
1.
Arunrungvichian K; Chongruchiroj S; Sarasamkan J; Schüürmann G; Brust P; Vajragupta O
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867140
[TBL] [Abstract][Full Text] [Related]
2. Selective α
Kanasuwan A; Deuther-Conrad W; Chongruchiroj S; Sarasamkan J; Chotipanich C; Vajragupta O; Arunrungvichian K
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835028
[TBL] [Abstract][Full Text] [Related]
3. Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.
Grishin AA; Cuny H; Hung A; Clark RJ; Brust A; Akondi K; Alewood PF; Craik DJ; Adams DJ
J Biol Chem; 2013 Nov; 288(48):34428-42. PubMed ID: 24100032
[TBL] [Abstract][Full Text] [Related]
4. QM-polarized ligand docking accurately predicts the trend in binding affinity of a series of arylmethylene quinuclidine-like derivatives at the α4β2 and α3β4 nicotinic acetylcholine receptors (nAChRs).
Kombo DC; Grinevich VP; Hauser TA; Sidach S; Bencherif M
Bioorg Med Chem Lett; 2013 Sep; 23(17):4842-7. PubMed ID: 23886687
[TBL] [Abstract][Full Text] [Related]
5. Varying Chirality Across Nicotinic Acetylcholine Receptor Subtypes: Selective Binding of Quinuclidine Triazole Compounds.
Sarasamkan J; Scheunemann M; Apaijai N; Palee S; Parichatikanond W; Arunrungvichian K; Fischer S; Chattipakorn S; Deuther-Conrad W; Schüürmann G; Brust P; Vajragupta O
ACS Med Chem Lett; 2016 Oct; 7(10):890-895. PubMed ID: 27774124
[TBL] [Abstract][Full Text] [Related]
6. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
[TBL] [Abstract][Full Text] [Related]
7. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR).
Kombo DC; Hauser TA; Grinevich VP; Melvin MS; Strachan JP; Sidach SS; Chewning J; Fedorov N; Tallapragada K; Breining SR; Miller CH
Bioorg Med Chem Lett; 2013 Mar; 23(5):1450-5. PubMed ID: 23352509
[TBL] [Abstract][Full Text] [Related]
9. Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
Kompella SN; Hung A; Clark RJ; Marí F; Adams DJ
J Biol Chem; 2015 Jan; 290(2):1039-48. PubMed ID: 25411242
[TBL] [Abstract][Full Text] [Related]
10. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.
Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ
J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000
[TBL] [Abstract][Full Text] [Related]
11. Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.
Kombo DC; Mazurov A; Tallapragada K; Hammond PS; Chewning J; Hauser TA; Vasquez-Valdivieso M; Yohannes D; Talley TT; Taylor P; Caldwell WS
Eur J Med Chem; 2011 Nov; 46(11):5625-35. PubMed ID: 21986237
[TBL] [Abstract][Full Text] [Related]
12. Multiple pharmacophores for the selective activation of nicotinic alpha7-type acetylcholine receptors.
Horenstein NA; Leonik FM; Papke RL
Mol Pharmacol; 2008 Dec; 74(6):1496-511. PubMed ID: 18768388
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.
Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P
Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805
[TBL] [Abstract][Full Text] [Related]
14. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies.
Peng W; Ding F
Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024
[TBL] [Abstract][Full Text] [Related]
15. Cross Talk between α7 and α3β4 Nicotinic Receptors Prevents Their Desensitization in Human Chromaffin Cells.
Jiménez-Pompa A; Sanz-Lázaro S; Omodolor RE; Medina-Polo J; González-Enguita C; Blázquez J; McIntosh JM; Albillos A
J Neurosci; 2022 Feb; 42(7):1173-1183. PubMed ID: 34965978
[TBL] [Abstract][Full Text] [Related]
16. Design of α7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.
Ouach A; Pin F; Bertrand E; Vercouillie J; Gulhan Z; Mothes C; Deloye JB; Guilloteau D; Suzenet F; Chalon S; Routier S
Eur J Med Chem; 2016 Jan; 107():153-64. PubMed ID: 26580980
[TBL] [Abstract][Full Text] [Related]
17. A conserved arginine with non-conserved function is a key determinant of agonist selectivity in α7 nicotinic ACh receptors.
Minguez-Viñas T; Nielsen BE; Shoemark DK; Gotti C; Sessions RB; Mulholland AJ; Bouzat C; Wonnacott S; Gallagher T; Bermudez I; Oliveira AS
Br J Pharmacol; 2021 Apr; 178(7):1651-1668. PubMed ID: 33506493
[TBL] [Abstract][Full Text] [Related]
18. Structure and allosteric activity of a single-disulfide conopeptide from
Mohan MK; Abraham N; R P R; Jayaseelan BF; Ragnarsson L; Lewis RJ; Sarma SP
J Biol Chem; 2020 May; 295(20):7096-7112. PubMed ID: 32234761
[TBL] [Abstract][Full Text] [Related]
19. Side Groups Convert the α7 Nicotinic Receptor Agonist Ether Quinuclidine into a Type I Positive Allosteric Modulator.
Viscarra F; Chrestia JF; Sanchez Y; Pérez EG; Biggin PC; Bouzat C; Bermudez I; López JJ
ACS Chem Neurosci; 2023 Aug; 14(16):2876-2887. PubMed ID: 37535446
[TBL] [Abstract][Full Text] [Related]
20. Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.
Matera C; Quadri M; Sciaccaluga M; Pomè DY; Fasoli F; De Amici M; Fucile S; Gotti C; Dallanoce C; Grazioso G
Eur J Med Chem; 2016 Jan; 108():392-405. PubMed ID: 26706350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
